Johnson & Johnson · New Brunswick, NJ United States · (NYSE: JNJ)
Company Description
- Dow Jones Global Titans
- #8 in FT Global 500
- #29 in FORTUNE 500
- S&P 500
- Dow Jones Industrials
This link will open in a new window It's nearly impossible to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three segments through more than 250 operating companies located in some 60 countries. Its Pharmaceuticals division makes drugs for an array of ailments, such as neurological conditions, blood disorders, autoimmune diseases, and pain. Top sellers are schizophrenia medication Risperdal and psoriasis drug Remicade. J&J's Medical Devices and Diagnostics division offers surgical equipment, monitoring devices, orthopedic products, and contact lenses, among other things. Its Consumer segment makes over-the-counter drugs and products for baby care, skin care, oral care, first aid, and women's health. To read the full description, subscribe now.
Johnson & Johnson Reports
Download presentation-ready reports for this company now.
Key Johnson & Johnson Financials
| Company Type | Public - NYSE: JNJ Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $63,747.0 |
| 2008 Employees | 118,700 |
Johnson & Johnson Executives
| Title | Name & Bio | Contact |
| Chairman and CEO | William Weldon | |
| VP Finance and CFO | Dominic Caruso | |
| VP and CIO | Laverne Council |